Strada, Lisa
Schmidt, Christiane Sybille http://orcid.org/0000-0003-1999-2073
Rosenkranz, Moritz
Verthein, Uwe
Scherbaum, Norbert
Reimer, Jens
Schulte, Bernd
Funding for this research was provided by:
Janssen-Cilag GmbH
Article History
Received: 10 August 2018
Accepted: 3 December 2018
First Online: 3 January 2019
Ethics approval and consent to participate
: Ethical approval was granted by the Ethics Committee of the Medical Association of Hamburg, Ref. PV4603, and by each local Ethics Committee in Germany.
: Not applicable; no details on individuals are reported within the manuscript
: JR received unrestricted educational grants, adviser and/or speakers remuneration from AbbVie, Desitin, Gilead, Janssen-Cilag, Mundipharma, Otsuka-Lundbeck, Hexal.NS received honoraria for several activities (advisory boards, lectures, manuscripts and educational material) by the factories AbbVie, Lundbeck, Medice, Mundipharma, Reckitt-Benckiser/Indivior, and Sanofi-Aventis. During the last three years he participated in clinical trials financed by the pharmaceutical industry.BS, UV, LS, CS, MR declare no potential conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.